Insolvency Notices

Company

BASILEA PHARMACEUTICALS LIMITED

Notice Type
Notices to Creditors
Publication date
22/12/2020
Edition
The London Gazette
Notice ID
3701492
Notice Code
2433

BASILEA PHARMACEUTICALS LIMITED

(Company Number 06131443)

Registered office: c/o Smith & Williamson LLP, 25 Moorgate, London, EC2R 6AY

Principal trading address: Onslow House, Onslow Street, Guildford, GU1 4TL

Notice is hereby given that creditors of the Company are required, on or before 5 February 2021, to prove their debts by delivering their proofs (in the format specified in Rule 14.4 of the Insolvency (England and Wales) Rules 2016) to the Joint Liquidators at Smith & Williamson LLP, 25 Moorgate, London, EC2A 6AY.

If so required by notice from the Joint Liquidators, creditors must produce any document or other evidence which the Joint Liquidators consider is necessary to substantiate the whole or any part of a claim.

Note: The Directors of the Company have made a declaration of solvency and it is expected that all creditors will be paid in full.

Date of Appointment: 15 December 2020

Office Holder Details: Mark Christopher Ford (IP No. 9521) and Henry Anthony Shinners (IP No. 9280) both of Smith & Williamson LLP, 25 Moorgate, London, EC2R 6AY

For further details contact: The Joint Liquidators, Tel: 020 7131 4909. Alternative contact: Liam Clarke

Mark Christopher Ford, Joint Liquidator

17 December 2020

Ag ZG91485